The Stock Exchange of Hong Kong (HKEX) has issued a Statement of Disciplinary Action against two former directors of China Health Technology (HKG:1069), according to its Wednesday bourse filing.
The duo namely Wang Yue, a former executive director, and Tian Guangmei, a former independent non-executive director, have been censured and deemed unsuitable to hold director or senior management positions.
This Director Unsuitability Statement signifies HKEX's opinion that the two are unfit for such roles within the company or its subsidiaries.
The Listing Committee found Mr. Wang breached Rule 3.08 regarding certain loans, while both Mr. Wang and Ms. Tian breached rules by failing to cooperate in the Division's investigation concerning a disposal.
Their actions were deemed a serious failure to discharge their responsibilities under the Listing Rules. It is clarified that these sanctions apply solely to the two named former directors.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。